|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 遗传性肥胖与心房颤动的关系显示文摘观察性研究已经确定了体质量指数(body mass index,BMI)与心房颤动之间的关联。然而,从观察性研究中推断因果关系会受到混杂因素、逆因果关系和偏倚的影响。该研究的主要目的是应用BMI的遗传学预测因子评估BMI与心房颤动之间的因果关系。方法:纳入1987-2002年期间在美国、冰岛和荷兰实施的7个前瞻性人群队列研究中基线无心房颤动的欧洲血统个体51 646人, | 刘莉 叶鹏 Chatterjee NA Giulianini F Geelhoed B Lunetta KL Misialek JR Niemeijer MN Rienstra M Rose LM Smith AV Arking DE Ellinor PT Heeringa J Lin H Lubitz SA Soliman EZ Verweij N Alonso A Benjamin EJ Gudnason V Stricker BH van der Harst P Chasman DI Albert CM | 2017 | 中华高血压杂志2017，25，2： | 2 |
| 2 | Serum potas-sium levels and the risk of atrial fibrillation: theRotterdam Study显示文摘 | Krijthe B P Heeringa J Kors J A | 2013 | Int J Cardiol2013，168，6： | 1 |
| 3 | Prevalence,incidence and lifetime risk of atrial fibrillatian:the rotterdam study显示文摘 | Heeringa J van der Kuip DA Hof-man A | 2006 | Eur Heart J2006，27，8： | 1 |
| 4 | lntracellular RIG-I Signaling Regulates TLR4-1ndependent Endothelial Inflammatory Responses to Endotoxin 显示文摘 | Moser J Heeringa P Jongman RM | 2016 | Jourual of Immunology2016，196，： | 1 |
| 5 | Neutrophil myeloperoxidase activity and the influence of two single-nucleotide promoter polymorphisms显示文摘 | RUTGERS A HEERINGA P GIESEN J E | 2003 | Br J Haematol2003，123，： | 1 |
| 6 | Preva-lence, incidence and lifetime risk of atrial fibrillation : the Rotterdam study 显示文摘 | Heeringa J van der Kuip DA Hofman A | 2006 | Eur Heart J2006，27，8： | 1 |
| 7 | Prevalence, incidenceand lifetime risk of atrial fibrillation: the Rotterdam study 显示文摘 | Heeringa J van der Kuip DAM Hofman A | 2006 | EurHeart J2006，27，8： | 1 |
| 8 | Prevalence, incidence and lifetime risk of atrial fibrillation:the Rotterdam study 显示文摘 | Heeringa J van der Kuip DA Hofman A | 2006 | Eur Heart J2006，27，8： | 1 |
| 9 | Cerebralmicrobleed preceding symptomatic intracerebralhemorrhage in a stroke-free person显示文摘 | Vernooij MW Heeringa J de Jong GJ | 2009 | Neurology2009，72，： | 1 |
| 10 | High-normal thyroid function and risk of atrial fibrillation:The rotterdam study显示文摘 | Heeringa J Hoogendoorn EH van der Deure WM | | 0，，： | 1 |
| 11 | Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study 显示文摘 | Heeringa J van der Kuip DA Hofman A | 2006 | Ear Heart2006，27，8： | 1 |
| 12 | Prevalence, incidenceand lifetime risk of atrial fibrillation: the Rotterdam study 显示文摘 | Heeringa J van der Kuip DA Hoftnan A | 2006 | EurHeart J2006，27，8： | 1 |
| 13 | Atrial fibrillation: is the prevalence rising? 显示文摘 | Heeringa J | 2010 | Eu-ropace2010，12，4： | 1 |
| 14 | Characterization of A Novel TRPC6 Mutant Identified In FSGS Patients显示文摘 | Du J Heeringa S F | 2009 | Biophysical J2009，96，3： | 1 |
| 15 | Drug-in-duced atrial fibrillation显示文摘 | van der Hooft CS Heeringa J van Herpen G | 2004 | J Am Coll Cardiol2004，44，11： | 1 |
| 16 | Prevalence,incidence and lifetime risk of atrial fibrillation:the Rotterdam study显示文摘 | Heeringa J van der Kuip DA Hofman A | 2006 | Eur Heart J2006，27，： | 1 |
| 17 | Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study显示文摘 | Heeringa J van der Kuip DA Hofman A | 2006 | Eur Heart J2006，27，8： | 1 |
| 18 | Preva- lence,incidence and lifetime risk of atrial fibrillation~ the Rot terdam study显示文摘 | Heeringa J van der Kuip D A M Hofman A | 2006 | Eur Heart J2006，27，8： | 1 |
| 19 | A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation:the Rotterdam Study 1990-1999显示文摘 | Heeringa J Conway DS van der Kuip DA | | 0，，： | 1 |
| 20 | Prevalence,incidence and lifetime risk of atrial fibrillation:the Rotterdam study显示文摘 | Heeringa J vander Kuip DA Hofman A | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员